CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
4% Albumin / 0.9% Sodium Chloridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00228657
NCT00228657Phase 2Completed
CompareCT.gov

The Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride Administration (Substudy of SAFE Protocol 153711)

Bayside Health·interventional·Posted Sep 29, 2005·Updated Nov 27, 2013

In Brief

A Phase 2 clinical trial evaluating 4% Albumin / 0.9% Sodium Chloride for Pressure Ulcer, Area and 4 related conditions. Completed, across 1 site.

Detailed Summary

Patients resuscitated with 4% Albumin will have less incidence and reduced severity of pressure injuries than patients resuscitated with 0.9% Sodium Chloride due to the improved intravascular oncotic pressure effected from higher albumin levels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPressure Ulcer, Area, Pressure Ulcer, Grade, Albumin Level, Risk Score, Length of ICU Stay
CountriesAustralia
Collaborators--

Timeline

Phase 2CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 29, 2005
Enrollment StartJul 1, 2002
Primary CompletionAug 1, 2003
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 20.8 years ago

Interventions

4% Albumin / 0.9% Sodium Chloridedrug